Ovine models for chronic heart failure

International Journal of Artificial Organs

Volumn 32, Issue 8, 2009, Pages 496-506

  Geens, Jef H ^a,b   Trenson, Sander ^a   Rega, Filip R ^a   Verbeken, Erik K ^a   Meyns, Bart P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Cardiovascular Diseases   (Belgium)

Author keywords

Animal models; Heart failure; Sheep

Indexed keywords

CARDIOLOGY; HEART; PATHOLOGY; SURGERY;

ANIMAL MODEL; ANIMAL SPECIES; CHRONIC HEART FAILURES; FAILURE MODELLING; HEART FAILURE; ISCHAEMIA; OCCLUSION REPERFUSION; OVINE MODEL; SHEEP; SURGICAL THERAPY;

ANIMALS;

AMIODARONE; ATENOLOL; BRETYLIUM; CARDIOTOXIN; LIDOCAINE; PROCAINAMIDE;

ANEURYSM; ARTICLE; ARTIFICIAL EMBOLISM; CARDIOMYOPATHY; CARDIOTOXICITY; CONTINUOUS INFUSION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG MEGADOSE; EXPERIMENTAL ANIMAL; EXPERIMENTAL SURGERY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PACING; ISCHEMIA; LOADING DRUG DOSE; MITRAL VALVE REGURGITATION; NONHUMAN; SHEEP; SURGICAL TECHNIQUE;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CARDIOMEGALY; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; SHEEP; SPECIES SPECIFICITY; VENTRICULAR FUNCTION;

EID: 70350557423     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880903200804     Document Type: Article

References (114)

1. Stewart S, Macintyre K, Capewell S, McMurray JJ. Heart falure and the aging population: an increasing burden in the 21st century? Heart 2003; 89: 49-53.
2. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 2009; 53: 13-20.
3. Power JM, Tonkin AM. Large animal models of heart failure. Aust N Z J Med 1999; 29: 395-402.
4. Yarbrough WM, Spinale FG. Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications. J Nucl Cardiol 2003; 10: 77-86.
5. Iannini JP, Spinale FG. The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models. J Heart Lung Transplant 1996; 15: 1138-50.
6. Succi GM, Moreira LF, Leirner AA, Silva RS, Stolf NA. Cavopulmonary anastomosis improves left ventricular assist device support in acute biventricular failure. Eur J Cardiothorac Surg 2009; 35: 528-33.
7. Shirakawa Y, Sawa Y, Takewa Y, et al. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices. J Thorac Cardiovasc Surg 2005; 130: 624-32.
8. Terrovitis JV, Charitos CE, Tsolakis EJ, et al. Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump. World J Surg 2003; 27: 1311-6.
9. Langer F, Rodriguez F, Cheng A, et al. Alterations in lateral left ventricular wall transmural strains during acute circumflex and anterior descending coronary occlusion. Ann Thorac Surg 2007; 84: 51-60.
10. Schmidt C, Schwendenwein I, Wieselthaler G, et al. Pharmacologically induced heart failure for the evaluation of circulatory assistance. Artif Organs 1996; 20: 685-8.
11. Jin YT, Hasebe N, Matsusaka T, et al. Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and beta-adrenergic desensitization. Am J Physiol Heart Circ Physiol 2007; 292: H1593-9.
12. Chachques JC, Grandjean PA, Cabrera Fischer EI et al. Dynamic aortomyoplasty to assist left ventricular failure. Ann Thorac Surg 1990; 49: 225-30.
13. Petzold T, Feindt P, Menger MD, Gams E. Beta-adrenoceptor inhibition for induction of acute cardiac failure in pigs. Lab Anim 1999; 33: 366-71.
14. Millner RW, Guvendik L, Clarke T, Hynd J, Pepper JR. Right ventricular dynamic cardiomyoplasty: an experimental model. Eur J Cardiothorac Surg 1991; 5: 311-4.
15. Tomoyasu M, Onizuka M, Inagaki M, et al. Effect of phosphodiesterase III inhibitor (Olprinone) on thoracic duct lymph flow in anesthetized sheep with experimentally induced heart failure by endothelin-1. Lymphology 2002; 35: 144-52.
16. Tweed WA, Davies JM, Alexander F, Csorba T, Weber S. Effects of isoproterenol-induced tachycardia on myocardial blood flow and glycogen in the fetal lamb. Biol Neonate 1987; 52: 104-14.
17. Jougasaki M, Heublein DM, Sandberg SM, Burnett JC, Jr. Attenuated natriuretic response to adrenomedullin in experimental heart failure. J Card Fail 2001; 7: 75-83.
18. Rutlen DL, Welt FG, Ilebekk A. Passive effect of reduced cardiac function on splanchnic intravascular volume. Am J Physiol 1992; 262: H1361-4.
19. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000; 36: 355-9.
20. Rokitansky AM, Losert UM, Trubel W, et al. Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output. Cardiovasc Res 1990; 24: 345-51.
21. Narayan SM, Drinan DD, Lackey RP, Edman CF. Acute volume overload elevates T-wave alternans magnitude. J Appl Physiol 2007; 102: 1462-8.
22. Moritz A, Fujimoto LK, Wollenek G et al. Sustained heart failure induced by repeated microsphere injections for left ventricular assist device testing. ASAIO Trans 1989; 35: 455-8.
23. Sabbah HN, Stein PD, Kono T et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991; 260: H1379-84.
24. Terp K, Kim WY, Ulrich M, et al. The hemodynamic impact of diffuse myocardial ischemic lesions: an animal experimental model based on intracoronary microembolization. Heart Vessels 1998; 13: 132-41.
25. Ikram H, Rogers SJ, Charles CJ et al. An ovine model of acute myocardial infarction and chronic left ventricular dysfunction. Angiology 1997; 48: 679-88.
26. Devlin G, Matthews K, McCracken G, et al. An ovine model of chronic stable heart failure. J Card Fail 2000; 6: 140-3.
27. Jugdutt BI. The dog model of left ventricular remodeling after myocardial infarction. J Card Fail 2002; 8: S472-5.
28. Kim WG, Cho SR, Sung SH, Park HJ. A chronic heart failure model by coronary artery ligation in the goat. Int J Artif Organs 2003; 26: 929-34.
29. Schuleri KH, Boyle AJ, Centola M, et al. The adult Gottingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp Med 2008; 58: 568-79.
30. Moainie SL, Gorman JH, III, Guy TS, et al. An ovine model of postinfarction dilated cardiomyopathy. Ann Thorac Surg 2002; 74: 753-60.
31. Markovitz LJ, Savage EB, Ratcliffe MB, et al. Large animal model of left ventricular aneurysm. Ann Thorac Surg 1989; 48: 838-45.
32. Millner RW, Mann JM, Pearson I, Pepper JR. Experimental model of left ventricular failure. Ann Thorac Surg 1991; 52: 78-83.
33. Bowen FW, Hattori T, Narula N, et al. Reappearance of myocytes in ovine infarcts produced by six hours of complete ischemia followed by reperfusion. Ann Thorac Surg 2001; 71: 1845-55.
34. Fukamachi K, Saeed D, Massiello AL, et al. Development of DexAide right ventricular assist device: update II. ASAIO J 2008; 54: 589-93.
35. Toyoda Y, Okada M, Kashem MA. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. J Thorac Cardiovasc Surg 1998; 115: 1367-73.
36. Christiansen S, Redmann K, Scheld HH, et al. Adriamycin-induced cardiomyopathy in the dog - an appropriate model for research on partial left ventriculectomy? J Heart Lung Transplant 2002; 21: 783-90.
37. Torrado M, Lopez E, Centeno A, Medrano C, Castro-Beiras A, Mikhailov AT. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J Mol Med 2003; 81: 566-77.
38. Borenstein N, Bruneval P, Behr L, et al. An ovine model of chronic heart failure: echocardiographic and tissue Doppler imaging characterization. J Card Surg 2006; 21: 50-6.
39. Tuzun E, Conger J, Gregoric ID, et al. Evaluation of a new cardiac recovery system in a bovine model of volume overload heart failure. ASAIO J 2004; 50: 557-62.
40. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996; 28: 375-85.
41. Kawase Y, Ly HQ, Prunier F, et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 2008; 51: 1112-9.
42. Travill CM, Williams TD, Pate P, et al. Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing. Cardiovasc Res 1992; 26: 783-90.
43. Sasayama S, Asanoi H, Ishizaka S. Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs. Eur Heart J 1992; 13 (Suppl E): S47-51.
44. Schoonderwoerd BA, Crijns HJ, Van Veldhuisen DJ, et al. Atrial natriuretic peptides during experimental atrial tachycardia: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2004; 15: 927-32.
45. Chow E, Woodard JC, Farrar DJ. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. Am J Physiol 1990; 258: H1603-5.
46. Byrne MJ, Raman JS, Alferness CA, Esler MD, Kaye DM, Power JM. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail 2002; 8: 108-15.
47. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79: 872-3.
48. Bloor CM, Nimmo L, McKirnan MD, Zhang Y, White FC. Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Mol Cell Biochem 1997; 176: 265-71.
49. Moorjani N, Catarino P, El-Sayed R, et al. A pressure overload model to track the molecular biology of heart failure. Eur J Cardiothorac Surg 2003; 24: 920-5.
50. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 1989; 65: 971-80.
51. Tessier D, Lajos P, Braunberger E, et al. Induction of chronic cardiac insufficiency by arteriovenous fistula and doxorubicin administration. J Card Surg 2003; 18: 307-11.
52. Chekanov VS, Tchekanov GV, Rieder MA, Hare J, Mortada M. Effects of electrical stimulation postcardiomyoplasty in a model of chronic heart failure: hemodynamic results after daily 12-hour cessation versus a nonstop regimen. Pacing Clin Electrophysiol 2000; 23: 1094-102.
53. Issa ZF, Rosenberger J, Groh WJ, Miller JM, Zipes DP. Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events. Heart Rhythm 2005; 2: 979-83.
54. Shen YT, Lynch JJ, Shannon RP, Wiedmann RT. A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs. Am J Physiol 1999; 277: H388-98.
55. Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep. Am J Physiol 1996; 270: H594-602.
56. Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H, Bagshaw P, Yandle TG. Neurohumoral changes during onset and offset of ovine heart failure: role of ANP. Am J Physiol 1989; 256: H1052-9.
57. Moreno J, Zaitsev AV, Warren M, et al. Effect of remodelling, stretch and ischaemia on ventricular fibrillation frequency and dynamics in a heart failure model. Cardiovasc Res 2005; 65: 158-66.
58. Byrne MJ, Kaye DM, Mathis M, Reuter DG, Alferness CA, Power JM. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation 2004; 110: 3088-92.
59. Power JM, Raman J, Byrne MJ, Alferness CA. Efficacy of the Acorn Cardiac Support Device in animals with heart failure secondary to high rate pacing. Heart Fail Rev 2005; 10: 117-23.
60. Rademaker MT, Charles CJ, Nicholls MG, Richards AM. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Clin Sci (Lond) 2008; 114: 635-42.
61. Raman JS, Byrne MJ, Power JM, Alferness CA. Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy. Ann Thorac Surg 2003; 76: 141-7.
62. Bertho E. [Normal comparative anatomy of the coronary arteries and veins of the hearts of different animal species (man, dog, calf, pig, sheep, horse, roe-deer and moose).]. Arch Anat Histol Embryol 1964; 47: 283-309.
63. Huang Y, Kawaguchi O, Zeng B, et al. A stable ovine congestive heart failure model. A suitable substrate for left ventricular assist device assessment. ASAIO J 1997; 43: M408-13.
64. Monreal G, Gerhardt MA, Kambara A, Abrishamchian AR, Bauer JA, Goldstein AH. Selective microembolization of the circumflex coronary artery in an ovine model: Dilated, ischemic cardiomyopathy and left ventricular dysfunction. J Card Fail 2004; 10: 174-83.
65. Schmitto JD, Ortomann P, Vorkamp T, et al. Histological changes in a model of chronic heart failure induced by multiple sequential coronary microembolization in sheep. J Cardiovasc Surg (Torino) 2008; 49: 533-7.
66. Zietkiewicz M, Perek B, Meyns B, et al. Chronic heart failure model induced by coronary embolization in sheep. Int J Artif Organs 1999; 22: 499-504.
67. Jiang L, Huang Y, Yuasa T, Hunyor S, dos Remedios CG. Elevated DNase activity and caspase expression in association with apoptosis in failing ischemic sheep left ventricles. Electrophoresis 1999; 20: 2046-52.
68. Jiang L, Huang Y, Hunyor S, dos Remedios CG. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 2003; 24: 742-51.
69. Huang Y, Hunyor SN, Jiang L, et al. Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. Am J Physiol Heart Circ Physiol 2004; 286: H2141-50.
70. Eng C, Cho S, Factor SM, Sonnenblick EH, Kirk ES. Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ Res 1984; 54: 74-82.
71. Ikeda Y, Yutani C, Huang Y, et al. Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy. Cardiovasc Pathol 2001; 10: 19-27.
72. Goldstein AH, Monreal G, Kambara A, et al. Partial support with a centrifugal left ventricular assist device reduces myocardial oxygen consumption in chronic, ischemic heart failure. J Card Fail 2005; 11: 142-51.
73. Kawaguchi O, Huang YF, Yuasa T, Shirota K, Carrington RA, Hunyor SN. Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression. Ann Thorac Surg 2002; 74: 1092-6.
74. Walker JC, Ratcliffe MB, Zhang P, et al. Magnetic resonance imaging-based finite element stress analysis after linear repair of left ventricular aneurysm. J Thorac Cardiovasc Surg 2008; 135: 1094-102.
75. Hasnat AK, van der Velde ET, Hon JK, Yacoub MH. Reproducible model of post-infarction left ventricular dysfunction: haemodynamic characterization by conductance catheter. Eur J Cardiothorac Surg 2003; 24: 98-104.
76. Charles CJ, Elliott JM, Nicholls MG, Rademaker MT, Richards M. Myocardial infarction with and without reperfusion in sheep: early cardiac and neurohumoral changes. Clin Sci (Lond) 2000; 98: 703-11.
77. Beeri R, Yosefy C, Guerrero JL et al. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol 2008; 51: 476-86.
78. Charles CJ, Elliott JM, Nicholls MG, Rademaker MT, Richards AM. Natriuretic peptides maintain sodium homoeostasis during chronic volume loading post-myocardial infarction in sheep. Clin Sci (Lond) 2003; 104: 429-36.
79. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000; 21: 1387-96.
80. Kim WG, Park JJ, Oh SI. Chronic heart failure model with sequential ligation of the homonymous artery and its diagonal branch in the sheep. ASAIO J 2001; 47: 667-72.
81. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
82. Rademaker MT, Cameron VA, Charles CJ, et al. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction. Am J Physiol Heart Circ Physiol 2000; 278: H731-40.
83. Millner RW, Burrows M, Pearson I, Pepper JR. Dynamic cardiomyoplasty in chronic left ventricular failure: an experimental model. Ann Thorac Surg 1993; 55: 493-501.
84. Mankad S, d'Amato TA, Reichek N, et al. Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling. Circulation 2001; 103: 2845-50.
85. Zhang P, Guccione JM, Nicholas SI, et al. Left ventricular volume and function after endoventricular patch plasty for dyskinetic anteroapical left ventricular aneurysm in sheep. J Thorac Cardiovasc Surg 2005; 130: 1032-8.
86. Blom AS, Pilla JJ, Gorman RC, et al. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep. Heart Fail Rev 2005; 10: 125-39.
87. Gorman JH, III, Gorman RC, Plappert T, et al. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg 1998; 115: 615-22.
88. Yankey GK, Li T, Kilic A, et al. Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model. J Thorac Cardiovasc Surg 2008; 135: 991-8.
89. Ghanta RK, Rangaraj A, Umakanthan R, et al. Adjustable, physiological ventricular restraint improves left ventricular mechanics and reduces dilatation in an ovine model of chronic heart failure. Circulation 2007; 115: 1201-10.
90. Llaneras MR, Nance ML, Streicher JT, et al. Large animal model of ischemic mitral regurgitation. Ann Thorac Surg 1994; 57: 432-9.
91. Gorman RC, McCaughan JS, Ratcliffe MB, et al. Pathogenesis of acute ischemic mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg 1995; 109: 684-93.
92. Ryan LP, Jackson BM, Parish LM, et al. Mitral valve tenting index for assessment of subvalvular remodeling. Ann Thorac Surg 2007; 84: 1243-9.
93. Tibayan FA, Rodriguez F, Langer F, et al. Annular or subvalvular approach to chronic ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2005; 129: 1266-75.
94. Leshnower BG, Sakamoto H, Hamamoto H, Zeeshan A, Gorman JH, Gorman RC. Progression of myocardial injury during coronary occlusion in the collateral-deficient heart: a non-wavefront phenomenon. Am J Physiol Heart Circ Physiol 2007; 293: H1799-804.
95. Psaltis PJ, Carbone A, Nelson A, et al. An ovine model of toxic, nonischemic cardiomyopathy - assessment by cardiac magnetic resonance imaging. J Card Fail 2008; 14: 785-95.
96. Borenstein N, Chetboul V, Bruneval P, et al. Non-cultured cell transplantation in an ovine model of non-ischemic heart failure. Eur J Cardiothorac Surg 2007; 31: 444-51.
97. Schutte PJ, Du Plooy WJ, Hay L. Some adverse cardiodynamic effects of prostaglandin E2 in congestive heart failure. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 207-10.
98. Aoyagi T, Mirsky I, Flanagan MF, Currier JJ, Colan SD, Fujii AM. Myocardial function in immature and mature sheep with pressure-overload hypertrophy. Am J Physiol 1992; 262: H1036-48.
99. Walther T, Falk V, Binner C et al. Experimental aortic stenosis and corresponding left ventricular hypertrophy in sheep. J Invest Surg 2000; 13: 327-31.
100. Aoyagi T, Fujii AM, Flanagan MF et al. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction. Circulation 1993; 88: 2415-25.
101. Moorjani N, Catarino P, Trabzuni D, et al. Upregulation of Bcl-2 proteins during the transition to pressure overload-induced heart failure. Int J Cardiol 2007; 116: 27-33.
102. Ashikaga H, Covell JW, Omens JH. Diastolic dysfunction in volume-overload hypertrophy is associated with abnormal shearing of myolaminar sheets. Am J Physiol Heart Circ Physiol 2005; 288: H2603-10.
103. Boudjemline Y, Pineau E, Bonnet C et al. Off-label use of an adjustable gastric banding system for pulmonary artery banding. J Thorac Cardiovasc Surg 2006; 131: 1130-5.
104. Sato H, Hall CM, Griffith GW, et al. Large animal model of chronic pulmonary hypertension. ASAIO J 2008; 54: 396-400.
105. Foti G, Kolobow T, Rossi F, Mandava S, Yamada K, Jones M. Cardiopulmonary bypass through peripheral cannulation with percutaneous decompression of the left heart in a model of severe myocardial failure. ASAIO J 1997; 43: 927-31.
106. Mihaylov D, Reintke H, Blanksma P, De Jong ED, Elstrodt J, Rakhorst G. Development of acute ischemic heart failure in sheep. Int J Artif Organs 2000; 23: 325-30.
107. Li Z, Gu YJ, Ye Q, et al. Hemodynamic support with the pulsatile catheter pump in a sheep model of acute heart failure. Artif Organs 2006; 30: 881-8.
108. Waldenberger FR, Meyns B, Reul H, Eilers R, Flameng W. Pre-clinical evaluation of a novel, pneumatic, ventricular assist device (Medos HIA-VAD) under pathophysiological conditions. Int J Artif Organs 1997; 20: 389-96.
109. Connolly MW, Lim KH, Rose DM, et al. Efficacy of right ventricular unloading during right coronary artery occlusion in an experimental model. Surgery 1986; 100: 143-9.
110. Darrah WC, Sharpe MD, Guiraudon GM, Neal A. Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thorac Surg 1997; 64: 1718-23.
111. Shum-Tim D, Duncan BW, Hraska V, Friehs I, Shin'oka T, Jonas RA. Evaluation of a pulsatile pediatric ventricular assist device in an acute right heart failure model. Ann Thorac Surg 1997; 64: 1374-80.
112. Birks EJ, Tansley PD, Hardy J et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006; 355: 1873-84.
113. Van de Werf F, Arnold AE. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ 1988; 297:1374-9.
114. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1993; 21: 683-91.